Beth Weinberg
Consigliere Generale presso CARA THERAPEUTICS, INC.
Posizioni attive di Beth Weinberg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CARA THERAPEUTICS, INC. | Consigliere Generale | - | - |
Storia della carriera di Beth Weinberg
Precedenti posizioni note di Beth Weinberg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANGN BIOM | Consigliere Generale | - | - |
| Metavant Sciences, Inc. | Consigliere Generale | - | - |
Formazione di Beth Weinberg
| Bradley University | Undergraduate Degree |
| Butler University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| General Counsel | 3 |
| Undergraduate Degree | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
| Metavant Sciences, Inc. | |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Borsa valori
- Insiders
- Beth Weinberg
- Esperienza
